" class="no-js "lang="en-US"> Company Releases Archives - Medtech Alert
Saturday, December 09, 2023

Sort by:


Top Post

One Million Checks Delivered By NHS ‘One Stop Shops’

NHS ‘one stop shops’ have delivered over one million checks and tests since the rollout […]

New £12.7M Centre of Excellence in Emerging Digital Technologies Officially Opens

The University of Liverpool’s Digital Innovation Facility (DIF), a £12.7 million Centre of Excellence in […]

Babylon GP At Hand Opens Two News Clinics For London Patients

Babylon GP at Hand has opened two new clinics situated in London that will provide […]

Minnesota Neurosurgeon Among First in Country to Perform Navigated Spine Fusions With Inspired Spine OLLIF Technology | Pharmtech Focus

Dr. Uzma Samadani, A Minneapolis neurosurgeon renowned for spine tumor resection and complex neurotrauma repair has completed 4 […]

Arrayjet Introduces Mercury Range of Next-generation Microarray Printers

Arrayjet, a leading provider of inkjet liquid-handling solutions, today introduced Mercury, a new core range of […]

Evonetix Granted Patent for Technology Enabling Thermally-controlled DNA Synthesis

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]

Owkin Announces New Scientific Advisory Board Chaired by World-leading Precision Oncologist

French-American AI for medical research startup Owkin today appointed ten advisors to its Scientific Advisory […]

NHS Announces £127m Maternity Boost for Patients and Families  

The NHS in England has today announced a £127 million funding boost for maternity services across […]

TendoNova wins FDA Clearance for Its New Microinvasive Ocelot Surgical Tool

TendoNova, an emerging leader in microinvasive sports medicine procedures, is pleased to announce the FDA […]

Seabelife Receives Close to €1.4m Deep Tech Financing from Bpifrance

SeaBeLife, a biotech company developing drug candidates intended to block cell necrosis, today announces that […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more